The Capitalist Newsletter – October 8, 2016

In This Article

The Capitalist Newsletter – October 8, 2016

SNAPCHAT PLANNING $25 BILLION IPO TO COMPETE WITH FACEBOOK

Snap, formerly known as Snapchat, is making waves with news of an upcoming IPO. But the real news here is the $25 billion valuation. Is this some random number or is the company worth it? How does an IPO help propel the company’s future? ….

Read The Capitalist’s Take Here…

Read More at BUSINESS INSIDER

Read More at HUFFINGTON POST


NFL RATINGS TUMBLE; SURPRISES NETWORKS AND ANALYSTS

TV networks are giving away more commercial time this NFL season than a year ago to make up for one of the worst ratings declines in a decade, a rare sign of weakness for the biggest draw on television.

Read More From Bloomberg Here

Read More From Wall Street Journal Here

Read More From USA Today Here


MYLAN TO PAY $465 MILLION TO SETTLE MEDICAID CLAIMS

Mylan, the maker of the allergy treatment EpiPen, said Friday that it had reached a $465 million settlement with the Justice Department and other government agencies over questions about whether the company had overcharged Medicaid for the EpiPen by improperly classifying it as a generic drug…

Read More From NY Times Here

Read More From The Wall Street Journal Here

Read More From USA Today Here


Closing Bell

-Friday, October 7th

Stocks Close Lower After Lackluster Jobs Report

Big Insider Trades

– Microsemi Corp. (MSCC) CEO, COO, SVP, & CFO Sell $5m

-Community Healthcare Trust, Inc. (CHCT) CEO Timothy Wallace Buys $250k

Winners & Losers

– Parkway Properties, Inc. (PKY) Goes UP (25.89%) After Closing Merger

– Clovis Oncology, Inc. (CLVS) Shares DOWN (15.10%) After Updated Study Results Reveal Safety Profile

Most Talked About

Lipocine, Inc. (LPCN) Wins Dismissal of Patent Infringement Lawsuit; Considered a Strong Buy via Social Chatter

The TIP Sheets

-Friday, October 7th

-Zumiez, Inc. (ZUMZ) Stock Ticks Up on Strong September Sales; Analyst Upgrade. Look for Shares to Continue UP

Unusual Volume

– Coty, Inc. (COTY) Falls (4.64%) on 86 Million Shares Traded After Proctor & Gamble Fell $1 Billion Short in Deal. Look For Shares to Continue DOWN

Related Articles

Scroll to Top